Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (281-290 of 721) with videos related to

Pageof 73
Sort By:
Radiology|October 14, 2025
PSMA PET/CT Reporting: Real-Life Inconsistencies, Heterogeneity, and Underutilization of Scoring Systems and Interpretation FrameworksHebert Alberto Vargas, Stefano Fanti, Ken Herrmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2017
Comparison of <sup>18</sup>F-FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer: a follow-up studyLino M Sawicki, Julian Kirchner, Johannes Grueneisen, et al.
Clinical Nuclear Medicine|December 5, 2013
Three-phase bone scintigraphy for imaging osteoradionecrosis of the jawConstantin Lapa, Christian Linz, Christina Bluemel, et al.
European Journal of Radiology|February 27, 2021
Correlation between contrast enhancement, standardized uptake value (SUV), and diffusion restriction (ADC) with tumor grading in patients with therapy-naive neuroendocrine neoplasms using hybrid <sup>68</sup>Ga-DOTATOC PET/MRINils Martin Bruckmann, Christoph Rischpler, Julian Kirchner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2025
Tumor Dose-Response Relationship of [<sup>131</sup>I]MIBG Therapy in Patients with Neural Crest Tumors by Means of [<sup>124</sup>I]MIBG PETAlexandros Moraitis, Andre Prochnow, Thorsten Dirk Poeppel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2026
Radiopharmaceutical Therapy Meets Radiobiology: Implications for Trial Design and DNA Repair Inhibitor CombinationsKatharina Lückerath, Pablo Mínguez Gabiña, Uta Eberlein, et al.
Cancer Research|September 5, 2006
A1 adenosine receptors in microglia control glioblastoma-host interactionMichael Synowitz, Rainer Glass, Katrin Färber, et al.
Molecular Imaging and Biology|April 3, 2009
Clinical value and limitations of [11C]-methionine PET for detection and localization of suspected parathyroid adenomasKen Herrmann, Toshiki Takei, Kakuko Kanegae, et al.
Infection|March 24, 2024
Hypercalcemia as a rare manifestation of immune reconstitution inflammatory syndrome (IRIS) in a person living with Human Immunodeficiency Virus (HIV) with disseminated nontuberculous mycobacteriosisMaximilian Webendoerfer, Margarethe Konik, Markus Zettler, et al.
Endocrine Connections|December 12, 2022
Predictive value of highly sensitive basal versus stimulated thyroglobulin measurement in long-term follow-up of thyroid cancerKim Magaly Pabst, Robert Seifert, Nader Hirmas, et al.
Pageof 73

Showing results (281-290 of 721) with videos related to

Sort By:
Pageof 73
Radiology|October 14, 2025
PSMA PET/CT Reporting: Real-Life Inconsistencies, Heterogeneity, and Underutilization of Scoring Systems and Interpretation FrameworksHebert Alberto Vargas, Stefano Fanti, Ken Herrmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2017
Comparison of <sup>18</sup>F-FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer: a follow-up studyLino M Sawicki, Julian Kirchner, Johannes Grueneisen, et al.
Clinical Nuclear Medicine|December 5, 2013
Three-phase bone scintigraphy for imaging osteoradionecrosis of the jawConstantin Lapa, Christian Linz, Christina Bluemel, et al.
European Journal of Radiology|February 27, 2021
Correlation between contrast enhancement, standardized uptake value (SUV), and diffusion restriction (ADC) with tumor grading in patients with therapy-naive neuroendocrine neoplasms using hybrid <sup>68</sup>Ga-DOTATOC PET/MRINils Martin Bruckmann, Christoph Rischpler, Julian Kirchner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2025
Tumor Dose-Response Relationship of [<sup>131</sup>I]MIBG Therapy in Patients with Neural Crest Tumors by Means of [<sup>124</sup>I]MIBG PETAlexandros Moraitis, Andre Prochnow, Thorsten Dirk Poeppel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2026
Radiopharmaceutical Therapy Meets Radiobiology: Implications for Trial Design and DNA Repair Inhibitor CombinationsKatharina Lückerath, Pablo Mínguez Gabiña, Uta Eberlein, et al.
Cancer Research|September 5, 2006
A1 adenosine receptors in microglia control glioblastoma-host interactionMichael Synowitz, Rainer Glass, Katrin Färber, et al.
Molecular Imaging and Biology|April 3, 2009
Clinical value and limitations of [11C]-methionine PET for detection and localization of suspected parathyroid adenomasKen Herrmann, Toshiki Takei, Kakuko Kanegae, et al.
Infection|March 24, 2024
Hypercalcemia as a rare manifestation of immune reconstitution inflammatory syndrome (IRIS) in a person living with Human Immunodeficiency Virus (HIV) with disseminated nontuberculous mycobacteriosisMaximilian Webendoerfer, Margarethe Konik, Markus Zettler, et al.
Endocrine Connections|December 12, 2022
Predictive value of highly sensitive basal versus stimulated thyroglobulin measurement in long-term follow-up of thyroid cancerKim Magaly Pabst, Robert Seifert, Nader Hirmas, et al.
Pageof 73